Skip to content
10-Q

Quarterly Report

Definium Therapeutics, Inc. DFTX

0001193125-25-269596

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 98.51M sh
Shares Diluted Q3 2025 · Sep 30, 2025 85.89M sh
Shares Diluted Q3 2025 · Sep 30, 2025 85.44M sh
Shares Diluted Q3 2025 · Sep 30, 2024 80.24M sh
Shares Diluted Q3 2025 · Sep 30, 2024 65.94M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$88.59M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$53.78M
Long Term Debt Q3 2025 · Sep 30, 2025 $40.39M
Short Term Investments Q3 2025 · Sep 30, 2025 $189.11M
Short Term Investments Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $19.96M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $273.74M
Stockholders Equity Q3 2025 · Sep 30, 2025 $130.6M
Stockholders Equity Q3 2025 · Jun 30, 2025 $185.4M
Stockholders Equity Q3 2025 · Mar 31, 2025 $222.81M
Stockholders Equity Q3 2025 · Dec 31, 2024 $241.45M
Stockholders Equity Q3 2025 · Sep 30, 2024 $262.19M
Stockholders Equity Q3 2025 · Jun 30, 2024 $202.05M
Stockholders Equity Q3 2025 · Mar 31, 2024 $196.06M
Stockholders Equity Q3 2025 · Dec 31, 2023 $78.13M
Current Liabilities Q3 2025 · Sep 30, 2025 $65.42M
Current Liabilities Q3 2025 · Dec 31, 2024 $38.85M
Total Liabilities Q3 2025 · Sep 30, 2025 $106.32M
Total Liabilities Q3 2025 · Dec 31, 2024 $60.7M
Current Assets Q3 2025 · Sep 30, 2025 $215.85M
Current Assets Q3 2025 · Dec 31, 2024 $281.62M
Total Assets Q3 2025 · Sep 30, 2025 $236.92M
Total Assets Q3 2025 · Dec 31, 2024 $302.15M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.78
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.56
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.27
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.78
Eps Basic Q3 2025 · Sep 30, 2025 −$1.56
Eps Basic Q3 2025 · Sep 30, 2024 −$0.18
Eps Basic Q3 2025 · Sep 30, 2024 −$1.12
Sga Expense Q3 2025 · Sep 30, 2025 $14.69M
Sga Expense Q3 2025 · Sep 30, 2025 $34.59M
Sga Expense Q3 2025 · Sep 30, 2024 $7.6M
Sga Expense Q3 2025 · Sep 30, 2024 $27.92M
Rd Expense Q3 2025 · Sep 30, 2025 $30.98M
Rd Expense Q3 2025 · Sep 30, 2025 $84.14M
Rd Expense Q3 2025 · Sep 30, 2024 $17.19M
Rd Expense Q3 2025 · Sep 30, 2024 $43.54M
Net Income Q3 2025 · Sep 30, 2025 −$67.27M
Net Income Q3 2025 · Sep 30, 2025 −$133.36M
Net Income Q3 2025 · Sep 30, 2024 −$13.68M
Net Income Q3 2025 · Sep 30, 2024 −$73.94M
Operating Income Q3 2025 · Sep 30, 2025 −$45.67M
Operating Income Q3 2025 · Sep 30, 2025 −$118.73M
Operating Income Q3 2025 · Sep 30, 2024 −$24.79M
Operating Income Q3 2025 · Sep 30, 2024 −$71.45M